Predict your next investment

Corporation

See what CB Insights has to offer

Investments

21

Portfolio Exits

13

About International Biomedicine Management Partners

International Biomedicine Management Partners Headquarter Location

Switzerland

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

International Biomedicine Management Partners Investments

21 Investments

International Biomedicine Management Partners has made 21 investments. Their latest investment was in Sunesis Pharmaceuticals as part of their PIPE - III on September 9, 2010.

CBI Logo

International Biomedicine Management Partners Investments Activity

investments chart

International Biomedicine Management Partners Portfolio Exits

13 Portfolio Exits

International Biomedicine Management Partners has 13 portfolio exits. Their latest portfolio exit was Enanta Pharmaceuticals on March 21, 2013.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/21/2013

IPO

$99M

2

10/21/2010

Acquired

$99M

1

12/21/2006

Acquired

10/14/2005

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

4/29/2004

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

3/21/2013

10/21/2010

12/21/2006

10/14/2005

4/29/2004

Exit

IPO

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

1

0

0

International Biomedicine Management Partners Team

1 Team Member

International Biomedicine Management Partners has 1 team member, including current Founder, Stefan Ryser.

Name

Work History

Title

Status

Stefan Ryser

Founder

Current

Name

Stefan Ryser

Work History

Title

Founder

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.